病理诊断

• Eyenuk Announces $6.2 Million Financing to Accelerate Adoption of FDA-cleared AI Technology for Detection of Diabetic Retinopathy 2021-07-20
• 获万孚生物数千万元A轮独家投资，赛维森科技如何在AI辅助病理诊断赛道脱颖而出？ 2021-06-21
• Lightspeed Microscopy, Inc. raises $4M in Series A Financing Round with Plans to Revolutionize Pathology 2021-06-15
• Guided Therapeutics Makes Final Payment to GPB Capital Holdings for Secured Notes 2021-01-13
• 迪英加再获近亿元B1轮投资，加速“AI+病理”辅助诊断产品开发 2020-12-04
• Press news Biocartis Group NV: Biocartis Receives EUR 1.2 million Grant for Development of Highly Innovative Idylla™ GeneFusion Assay 2020-09-30
• ClinSpec Diagnostics Raises £2.4M Funding 2020-09-07
• 贝格尔宣布完成A轮融资，致力于成为神经退行性疾病早期诊断及精准治疗领军企业 2020-08-12
• Retina-AI Health Raises $5.2M in Funding 2020-08-07
• Acarix decides on a guaranteed rights issue of approximately SEK 56 million 2020-07-15

登录医药魔方官网 查看更多资讯